| Home >
News Room >
The US Oncology Network in the News |
 |
| The US Oncology Network in the News
|
|
Read about us in the news to learn how the more than 1,000 physicians and over 9,000 cancer professionals in The US Oncology Network advance cancer care in America.
|
Television News
|
The Today Show: Family faces breast cancer together
|
WUSA9: Dr. Neelima Denduluri, Virginia Cancer Specialists, Discusses Fears Over Chemotherapy After Roberts' Announcement
|
ABC 15: Screening still vital in prostate cancer, Arizona doctor discusses treatments
|
PBS News Hour: Drug Hoarders, Manufacturing Cuts Exacerbate Shortage of Key Medications
|
Inside Business Reports: Advancements in Cancer Treatment and Care
One patient's path to remission and the role that US Oncology Research plays in enabling community-based oncology practices to successfully offer cutting-edge clinical trials.
|
|
21st Century Health: Innovative Cancer Treatment Solutions
|
WFMJ-TV NBC: Providing cancer treatment to those who cannot afford it
|
Blomberg: McKesson to purchase US Oncology
|
Articles
|
MedPage Today: No Excess Risk of AML, MDS after Chemo
|
Oncology Business Review: Relating Value in Cancer Care to Cost and Outcome
|
Cancer Network: ASCO Breast: DNA-Damaging Therapies Emerging as Possible Triple-Negative Breast Cancer Therapies
|
The Courier of Montgomery County: McKesson, US Oncology employees make 750 care packages for military
|
Medscape: The Right EHR for an Oncology Practice
|
Oncology Times: Pathway or Pathways? Major Pennsylvania Insurer Takes a Stand, But Now a Long-Time Partnership Has Turned Difficult
|
Biotechnology Healthcare: Will Clinical Pathways Work?
|
The New York Times: Insurers Test New Cancer Pay Systems
|
The Wall Street Journal: In Treating Cancer, Insurer Tries New Way to Pay Docs
|
Chicago Tribune: Patient Assistance Support
|
|
Bureau of National Affairs: BNA Q & A: Risk Contracting Model for Oncologists and Payers
|
|
HemOnc Today: Small cell lung cancer requires complex therapeutic strategies
|
Tyler Morning Telegram: Clinical Trials Pivotal In Drug Development
|
Information Week: BI Made Easier For Healthcare
|
Odessa American Daily: Clinical Trials
|
HemOnc Today: REMS for ESAs: The FDA mandated program is under scrutiny
|
HemOnc Today: Hematologic Malignancies
|
Cancer Network: Evidence-based pathway plus electronic health records system matches major trials for colorectal cancer treatment outcomes
|
North Bay Business Journal: Redwood Regional joins nationwide network of oncologists
|
Houston Business Journal: Collaboration Creates Cancer Center
|
Woodlands Online: Memorial Hermann, Texas Oncology And US Oncology Partner
|
KSAT 12: Cancer Patients Get Spa Services During Treatment
|
Las Vegas Review Journal: TREATMENT QUALITY: Care, research attract visitors
|
Dallas Morning News: Cancer doctors weigh in with opinions on travel
|
Dallas Morning News: The trip treatment: Traveling during cancer care
|
AIS's Health Business Daily: Studies Show EMR Data Can Provide a More Nuanced Look at Outcomes
|
Oncology Times: Cancer Care Pathways Catching on with Payers
US Oncology’s Innovent Oncology was featured in a story on pathways in the third article of a series carried in Oncology Times. The article shows a fair balance between Innovent Oncology, P4 healthcare and Via Oncology.
|
|
Pharmawire article on Celgene's Revlimid
|
|
Pharmawire article on Provenge
|
|
ONC Live: US Oncology’s Payer Quality Services Aims High
|
Article: Houston Chronicle Leading Companies
US Oncology ranked #6 in the private sector of Houston Chronicle's list of Leading Companies
|
|
Pharmawire article on melanoma May 2010
|
|
Houston Business Journal: US Oncology unveils new brand campaign
|
|
Pharmawire article: Poniard pushes forward with picoplatin in small cell lung cancer despite prior failure; oncologists cautious about success
|
|
Pharmawire article: Abraxis: Abraxane must show major clinical benefit over generic paclitaxel for widespread use, physicians say
|
|
Journal of Oncology Practice article: Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting
|
|
Pharmawire article: Eisai and Supergen's Dacogen expected to demonstrate positive results in DACO-016 trial in AML, hematologists/oncologists say
|
|
Pharmawire article: Sunesis’ voreloxin offers modest response rates, but encouraging toxicity in AML – hematologists
|
|
Wall Street Journal article Women's Health
|
|
Nevada Business Magazine: Nevada Business Magazine - Healthcare Heroes
James Kilber profile for Top Administrator in Southern Nevada (page 7)
|
|
Nevada Business Magazine: Nevada Business Magazine - Healthcare Heroes
Dr. Mary Ann Allison profile for Caregiver of the Year in Southern Nevada (page 8)
|
|
The Roanoke Times: Cross-country bike trip for cancer ends in celebration
|
Tampa Bay Times: Florida Cancer Affiliates opens site in New Port Richey
|
US News & World Reports: Experimental Drugs Do Battle Against Advanced Prostate Cancer
|
Reuters: Breast cancer kills older women more often
|
Studies
|
The Oncologist: Bevacizumab Treatment to Progression After Chemotherapy: Outcomes from a U.S. Community Practice Network
|
Innovent/Milliman Study: Cancer Patients Receiving Chemotherapy: Opportunities for Better Management
|
|
Journal of Oncology Practice: Pathways, Outcomes, and Costs in Colon Cancer: Retrospective Evaluations in Two Distinct Databases
|
|
Podcasts
|
Health Business Blog: Drug assistance programs for insured patients? A conversation with AccessMED
|
Podcast from HemOncTown eNews featuring US Oncology Chief Scientific Officer Daniel Von Hoff, M.D., F.A.C.P.
The ASCO 2010 David A. Karnofsky Memorial Award recipient reflects on the future of oncology therapeutics and logistics.
|
|
Podcast from HemOncTown eNews featuring Texas Oncology's John V. Cox, D.O., F.A.C.P.
The ASCO 2010 Statesman Award recipient provides his observations on the future of oncology therapeutics and logistics.
|
|
AHIP BRIDGECAST:Reducing Variations In Cancer Care And Improving Cost-Effectiveness With Evidence-Based Pathways
This discussion, featuring Dr. Marcus Neubauer, Kansas City Cancer Center, outlines the evidence-based pathways Innovent Oncology has developed with providers to improve health outcomes while reducing variations in cancer care and improving cost-effectiveness.
|
Blogs
|
Oncology Business Review: McKesson Buys US Oncology: What Does This Further Consolidation of the Specialty Pharmaceutical Channel Mean To Manufacturers?
|
Software Advice: US Oncology iKnowMed EHR Medical Software
|
Blayney blog on iKnowMed
|
Blankenhorn blog on iKnowMed Technology Platform from ZDNet
|
ASCO 2010-Cabazitaxel second line for prostate castration resistant cancer
|
|
